Repligen (RGEN) Invested Capital (2013 - 2026)

Repligen (RGEN) has reported Invested Capital for 14 consecutive years, with $2.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital rose 28.42% year-over-year to $2.7 billion in Q2 2026; TTM through Jun 2026 was $2.7 billion, a 28.42% increase from a year earlier, with the FY2025 full-year figure at $2.7 billion, up 5.49% from the prior year.
• Invested Capital was $2.7 billion for Q2 2026 at Repligen, roughly flat from $2.7 billion in the prior quarter.
• Over five years, Invested Capital peaked at $2.7 billion in Q2 2026 and troughed at $2.0 billion in Q1 2025.
• A 5-year average of $2.3 billion and a median of $2.2 billion in 2022 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital retreated 10.64% in 2024 and surged 31.06% in 2026, its largest moves.
• Over 5 years, Invested Capital stood at $2.2 billion in 2022, then dropped by 7.33% to $2.0 billion in 2023, then advanced by 22.87% to $2.5 billion in 2024, then advanced by 5.49% to $2.7 billion in 2025, then increased by 0.48% to $2.7 billion in 2026.
• The last three Invested Capital figures came in at $2.7 billion (Q2 2026), $2.7 billion (Q1 2026), and $2.7 billion (Q4 2025), per Business Quant data.